EpicBioCMYK300dpi.png
Epic Bio to Present at the Upcoming Charles River Cell and Gene Therapy Summit
March 13, 2024 16:00 ET | Epic Bio
SOUTH SAN FRANCISCO, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- Epic Bio, a leading epigenetic editing company that plans to dose its first patients later this year, today announced that Amber...
22157.jpg
Epigenetics Market Research Report 2023 - Global Forecast to 2030 with Market Share Analysis of Merck, 10X Genomics, Thermo Fisher Scientific, Illumina, and QIAGEN
March 01, 2024 04:11 ET | Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Epigenetics Market by Offering (Kits, Reagents, Instruments, Software) Method (DNA Methylation, PCR, Chromatin Analysis, Histone, RNA Modification),...
Logo.jpg
Epigenetics Market To Reach USD 7.9 Billion By 2032 Report By DataHorizzon Research
January 19, 2024 06:30 ET | DataHorizzon Research
Fort Collins, Colorado, Jan. 19, 2024 (GLOBE NEWSWIRE) -- The Epigenetics Market size was valued at USD 1.8 Billion in 2022 and is expected to reach a market size of USD 7.9 Billion by 2032 with a...
Global Epigenetics Diagnostics Market
Epigenetics Diagnostics Market to 2028 - Key Market Drivers & Challenges
January 18, 2024 21:03 ET | Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Epigenetics Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
22157.jpg
Global Metagenomics Market Analysis 2023-2027: Breakthrough Insights in Medical Treatment and Microbiome Research by Application, Technology, Product and User
January 16, 2024 11:18 ET | Research and Markets
Dublin, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The "Metagenomic Markets: Global Market Analysis with Forecasts by Applications, Technologies, Product and User. With Executive and Consultant Guides. 2023...
website-logo (2).png
Epigenetics Market Predicted to Garner USD 12.7 Billion By 2033, At CAGR 19.2% | Exclusive Report by Marketresearch.biz
January 16, 2024 03:58 ET | MarketResearch.biz
New York, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The epigenetics market was valued at USD 2.3 billion in 2023 with a significant growth and is projected to reach at USD 12.7 billion by 2033 with a CAGR...
Global Epigenetics Market
Global Epigenetics Market Poised for Rapid Growth - Asia-Pacific Region to Witness Extensive Expansion by 2028
January 03, 2024 09:03 ET | Research and Markets
Dublin, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The "Global Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Instrument, Software), Method...
Emergen logo.png
Cancer Tumor Profiling Market Size Worth USD 32.72 Billion by 2032 | Emergen Research
December 11, 2023 08:15 ET | Emergen Research
Vancouver, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The Cancer Tumor Profiling Market is expected to reach USD 32.72 Billion by 2032, according to a new report by Emergen Research. This market's growth is...
EpicBioCMYK300dpi.png
Epic Bio to Present at the Upcoming CRISPR2.0 Conference
November 21, 2023 12:00 ET | Epic Bio
SOUTH SAN FRANCISCO, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today...
EpicBioCMYK300dpi.png
FDA Grants Orphan Drug Designation to EPI-321, Epic Bio's Novel Genetic Medicine Candidate for Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)
November 16, 2023 06:00 ET | Epic Bio
- Potential one-time therapy for the treatment of FSHD includes a novel non-cutting dCas protein delivered via a single AAV - - EPI-321 is the only therapy designed to target the epigenetic root...